-
There is an urgent need for a new TB vaccine, as the only current vaccine against TB is 100 years old with limited effectiveness.
This fact sheet summarizes the current challenges and opportunities for TB research and development, emphasizing the need to fund the development of a TB vaccine to enable us to get back on track to ending TB.
-
“Words Matter” is a flagship communications tool developed by the Stop TB Partnership for partners, stakeholders, and anyone affected or working in TB. The guide is a key instrument to encourage positive change, sensitize, promote appropriate language, end the stigmatization, and empower people affected by TB.
-
The Stop TB Canada network is pleased to share our first joint publication - a comprehensive fact sheet on tuberculosis with calls to action tailored for advocates in Canada. This resource will be shared widely to increase awareness of TB and articulates what is needed to achieve TB elimination goals in Canada and abroad.
-
“Nourish to Flourish” is a a youth-led, community-centered guide that highlights the critical role of nutrition in preventing TB and improving treatment outcomes.
This easy-to-use resource includes practical tips, powerful country examples, and a strong call to action for policymakers, communities, and healthcare providers to integrate nutrition into TB responses.
-
Public health measures to contain the pandemic are adversely affecting TB service provision in many countries. WHO’s Global TB report documented fewer monthly notifications of TB disease in 14 high-TB burden countries, at times for successive months and coinciding with measures to limit population mobility in response to the pandemic. If this situation is left unchecked, modelling predicts that such disruptions in TB detection and treatment could significantly increase TB incidence and mortality. The global resolve to end TB is therefore a necessity to prevent further resurgence of the epidemic.
-
‘Psychosocial counselling and treatment adherence support for people affected by tuberculosis’ is a new technical manual created by TB Alert, with support from The Union, the World Health Organization (WHO) and the Stop TB Partnership (STBP). It aims to fill a gap which frequently exists in current practice, by focusing on the psychosocial needs of clients caused by the social determinants of health and related factors.
-
In 2024, the World Health Organization (WHO) issued a rapid communication with key updates to its guidelines for treating drug-resistant TB. The six-month regimen — known as BPaL(M) — recommended by the WHO since 2022, remains the preferred treatment option for drug-resistant TB. The new WHO guidelines also support the use of six- and nine-month, pretomanid-sparing regimens. These alternative regimens now endorsed by the WHO are especially important for enabling children, younger adolescents, pregnant women and persons, and other populations that are otherwise excluded from access to the six-month BPaL(M) regimen to benefit from shorter treatment regimens for drug-resistant TB.
The new 2025 update of An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB. The Activist Guide reviews the evidence-base behind these regimens, important considerations for key populations affected by TB, the access landscape, and more. The publication is intended to equip advocates with information they need to formulate arguments and push for universal implementation of the best available treatments.